US 11207518 — Patent Expiration

TREATING INFLAMMATORY DISORDERS BY STIMULATION OF THE CHOLINERGIC ANTI-INFLAMMATORY PATHWAY

Shareable link — bookmark or send to anyone

www.patentreply.ai/tools/patent-expiration/US11207518

Important: This calculator does not include patent term extension under 35 U.S.C. § 156, which may apply to certain drug, biologic, animal drug, and medical device patents.

Learn more about PTE and patent expiration

US 11207518

Treating Inflammatory Disorders By Stimulation Of The Cholinergic Anti-inflammatory Pathway

High Confidence

Application No. 12259208

March 29, 2027

282 days remaining

Earliest effective filing

Dec 22, 2005

+ 20 years

Dec 22, 2025

PTA +462d

Mar 29, 2027

No TD

—

Final

Mar 29, 2027

This calculation includes Patent Term Adjustment (PTA) under 35 U.S.C. §154(b). Patent Term Extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation Details

Base Term Calculation

Filing Date

October 27, 2008

Earliest Effective Filing

December 22, 2005

Issue Date

December 28, 2021

PTA

+462 days

Base Expiry (before PTA)

December 22, 2025

December 22, 2005 + 20 years = December 22, 2025 + 462 PTA days = March 29, 2027

Continuation-in-Part of application 11318075, filed Dec 22, 2005, issued as US 11344724

PRO

60639332 — Provisional — not used for base term

PRO

60639332 — Provisional — not used for base term

PRO

60982681 — Provisional — not used for base term

Terminal Disclaimer Analysis

No TD

0 approved, 0 filed

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.